Advances in genetic testing for Alzheimer's disease

Area of Science:

• Neurology
• Genetics
• Geriatrics

Background:

• Alzheimer's disease (AD) is the most common dementia in the elderly, with increasing prevalence.
• Neurologists face growing questions regarding genetic testing for dementia.
• Current genetic testing options have evolved but remain limited.

Purpose of the Study:

• To review the current status and utility of genetic testing for Alzheimer's disease.
• To inform neurologists and patients about the appropriate use of genetic testing.
• To highlight the importance of genetic counseling in the process.

Main Methods:

• Review of current clinical genetic testing options for dementia.
• Analysis of the utility of genetic testing for diagnosis and prediction.
• Emphasis on the role of genetic counseling.

Main Results:

• Clinical genetic testing has expanded to include genes like APOE, PSEN1, PSEN2, and APP.
• Genetic testing is not currently appropriate for most AD patients and has limited predictive value.
• Further research is expected to increase the usefulness of genetic testing.

Conclusions:

• Genetic testing for Alzheimer's disease is evolving but currently has limited clinical utility for most individuals.
• Comprehensive genetic counseling is a critical component of the genetic testing process.
• Future research may broaden the application of genetic testing in dementia care.